Fluorescein versus Indocyanine Green Angiography Guided Half-Dose Photodynamic Therapy for Chronic Central Serous Chorioretinopathy

被引:1
|
作者
Moodi, Farzan [1 ,2 ]
Naseripour, Masood [1 ,2 ,3 ]
Zand, Amin [1 ,2 ]
Mirshahi, Reza [1 ,2 ]
Moodi, Vihan [4 ]
Alemzadeh, Sayyed Amirpooya [1 ,2 ]
Falavarjani, Khalil Ghasemi [1 ,2 ,3 ,5 ]
机构
[1] Iran Univ Med Sci, Senses Hlth Inst 5, Eye Res Ctr, Rassoul Akram Hosp,Sch Med, Tehran, Iran
[2] Iran Univ Med Sci, Senses Hlth Inst 5, Dept Ophthalmol, Rassoul Akram Hosp,Sch Med, Tehran, Iran
[3] Iran Univ Med Sci, Stem Cell & Regenerat Med Res Ctr, Tehran, Iran
[4] Univ Tehran Med Sci, Sch Med, Tehran, Iran
[5] Rassoul Akram Hosp, Eye Res Ctr, Sattarkhan Niaiesh St, Tehran 14456, Iran
关键词
Central Serous Chorioretinopathy; Fluorescein Angiography; Indocyanine Green Angiography; Photodynamic Therapy; VERTEPORFIN;
D O I
10.18502/jovr.v19i1.15420
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To compare the outcomes of fluorescein angiography (FA)-guided and indocyanine green angiography (ICGA)-guided half-dose photodynamic therapy (PDT) in patients with chronic central serous chorioretinopathy (CSC). Methods: In this retrospective comparative study, medical records of eyes with chronic CSC who underwent half-dose PDT were reviewed. A retina specialist performed FA-guided half-dose PDT, and the other performed ICGA-guided treatment. The success of applying PDT in the resolution of subretinal fluid was compared between the FA- and ICGA-guided methods. Results: Eighty-two eyes of 73 patients (41 eyes in each group) received half-dose PDT. After halfdose PDT, a significant improvement in the best-corrected visual acuity (BCVA) was found at the time of the last follow-up in both groups (both P < 0.001), with no significant intergroup difference. Central subfield and subfoveal choroidal thicknesses decreased significantly in both groups at the last follow-up (all P < 0.05), with no significant differences between the groups. Subretinal fluid (SRF) resolved in all eyes, and no persistent SRF was detected during the follow-up period. Conclusion: FA-guided and ICG-guided half-dose PDT may have similar efficacy for the treatment of chronic CSC.
引用
收藏
页码:12 / 17
页数:6
相关论文
共 50 条
  • [31] Long-term efficacy of half-dose photodynamic therapy on chronic central serous chorioretinopathy
    Tseng, Chien-Chi
    Chen, San-Ni
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2015, 99 (08) : 1070 - 1077
  • [32] Half-dose vs one-third-dose photodynamic therapy for chronic central serous chorioretinopathy
    Uetani, R.
    Ito, Y.
    Oiwa, K.
    Ishikawa, K.
    Terasaki, H.
    EYE, 2012, 26 (05) : 641 - 648
  • [33] Microstructural changes after half-dose photodynamic therapy in patients with chronic central serous chorioretinopathy
    Esen, Ebru
    Sizmaz, Selcuk
    Demircan, Nihal
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2021, 35
  • [34] Changes in macular sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy
    Atik, Alp
    Hu, Yijun
    Yu, Honghua
    Yang, Chun
    Cai, Bin
    Tao, Yijing
    Li, Dongli
    Chen, Yan
    Lu, Li
    Li, Guodong
    Yuan, Ling
    BMC OPHTHALMOLOGY, 2017, 17
  • [35] Half-dose photodynamic therapy for chronic central serous chorioretinopathy evaluated by focal macular electroretinograms
    Oiwa, Kazuhiro
    Kataoka, Keiko
    Maruko, Ruka
    Ueno, Shinji
    Ito, Yasuki
    Terasaki, Hiroko
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2017, 61 (03) : 260 - 266
  • [36] Half-dose photodynamic therapy for chronic central serous chorioretinopathy evaluated by focal macular electroretinograms
    Kazuhiro Oiwa
    Keiko Kataoka
    Ruka Maruko
    Shinji Ueno
    Yasuki Ito
    Hiroko Terasaki
    Japanese Journal of Ophthalmology, 2017, 61 : 260 - 266
  • [37] The safety of fovea-involving half-dose photodynamic therapy for chronic central serous chorioretinopathy
    Feenstra, H. M. A.
    Diederen, R. M. H.
    Lamme, M. J. C. M.
    Fauser, S.
    Downes, S. M.
    Schlingemann, R. O.
    Hoyng, C. B.
    van Dijk, E. H. C.
    Boon, C. J. F.
    ACTA OPHTHALMOLOGICA, 2022, 100 : 19 - 19
  • [38] Changes in macular sensitivity after half-dose photodynamic therapy for chronic central serous chorioretinopathy
    Alp Atik
    Yijun Hu
    Honghua Yu
    Chun Yang
    Bin Cai
    Yijing Tao
    Dongli Li
    Yan Chen
    Li Lu
    Guodong Li
    Ling Yuan
    BMC Ophthalmology, 17
  • [39] Real-World Experience with Half-Time Versus Half-Dose Photodynamic Therapy in Chronic Central Serous Chorioretinopathy
    Peng, Shu-Yen
    Lai, Chi-Chun
    Wang, Nan-Kai
    Wu, Wei-Chi
    Hwang, Yih-Shiou
    Chen, Kuan-Jen
    Chen, Lee-Jen
    Tsai, Shawn
    Chan, Wei-Chun
    Liu, Laura
    Yeung, Ling
    JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2017, 33 (06) : 466 - 472
  • [40] Optical coherence tomography angiography-guided vs indocyanine green angiography-guided half-dose photodynamic therapy for acute central serous chorioretinopathy: 6-month randomized trial results
    Li, Siying
    Zhang, Linqi
    Tang, Jiyang
    Wang, Zongyi
    Qu, Jinfeng
    Zhao, Mingwei
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2023, 261 (11) : 3149 - 3158